Abatacept as a successful therapy for myositis—a case-based review. - Wikidata - wikimedia - TriplyDB

Abatacept as a successful therapy for myositis—a case-based review.

Abatacept as a successful therapy for myositis—a case-based review.

http://www.wikidata.org/entity/Q38184953

about

Treatment of inflammatory myopathy: emerging therapies and therapeutic targets Immunotherapies for Immune-Mediated Myopathies: A Current Perspective Biologic therapies for refractory juvenile dermatomyositis: five years of experience of the Childhood Arthritis and Rheumatology Research Alliance in North America.Drugs in induction and treatment of idiopathic inflammatory myopathies Modern Therapies for Idiopathic Inflammatory Myopathies (IIMs): Role of Biologics.Innate immune-response mechanisms in dermatomyositis: an update on pathogenesis, diagnosis and treatment.Cytokines in immune-mediated inflammatory myopathies: cellular sources, multiple actions and therapeutic implications.Idiopathic inflammatory myopathies-a review.Idiopathic inflammatory myopathies: from immunopathogenesis to new therapeutic targets.Treatment of Juvenile Dermatomyositis: An Update.Update on the pharmacological treatment of adult myositis.Long-term efficacy of alemtuzumab in polymyositis.

P2860

Q26796546-CA272653-351D-47B4-A672-D13907C9E41A Q30699742-79E88A36-1646-426B-9DF7-ED3038B3EFB3 Q33795594-503B051A-C832-4398-979D-31BE1C76CFE8 Q35281940-D9DE0A67-FE09-484B-8177-135A496B6D4F Q37095730-AA996CBA-3FA3-4B59-8B59-5304297F4E7B Q38221095-DA55861E-D684-47CC-B8B6-254F7576AC4C Q38244567-7B079266-EFA1-49BE-8769-A3E21682E40D Q38355216-1C0DE707-5488-4F71-9DD3-A688448BDF0C Q38589301-847A575F-FE7C-4900-8E96-F18F5E8FAA0D Q38678257-F3CBC168-3F05-4CE0-BA77-9F0080933618 Q38813275-D20F4557-AFD3-403C-B58D-7BAC04D194DF Q43155378-B225C472-48D0-4E3B-B987-FBF0F2658228

P2860

Abatacept as a successful therapy for myositis—a case-based review.

http://www.wikidata.org/entity/Q38184953

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Abatacept as a successful therapy for myositis—a case-based review.

@en

type

label

Abatacept as a successful therapy for myositis—a case-based review.

@en

prefLabel

Abatacept as a successful therapy for myositis—a case-based review.

@en

P1433

Q38184953-D4F6FE27-743B-42C5-B28E-08768DB3FABB

P1476

Q38184953-47FD0FD7-9F18-4BCE-8FE5-9E44B660869A

P2093

Q38184953-70108D58-67BA-495D-9802-CC959881C0B5

Q38184953-C13908FA-036E-4F63-A7BD-056EC405CACC

P2860

Q38184953-127C1B18-B4B0-47D4-ADA1-259EFACC2461

Q38184953-23BB4EBC-A5BE-45E4-9AF1-4DAB49B03113

Q38184953-2BBC9E17-6434-4B78-9F46-03DE7D2168CA

Q38184953-5E9FA772-430C-447D-B163-42EAEEBA3A40

Q38184953-6610C57C-88DA-4423-931E-5CE5AA467CE1

Q38184953-6A2A0DB1-4383-4D49-BDFD-8ABD5A8C4AEC

Q38184953-6B612D5E-C75C-4EC7-BE47-4B4426DBB9B9

Q38184953-81A3CEF0-9E3D-46FA-B5C8-77F18DC6415C

Q38184953-8316913C-C2F4-4058-A6B0-11EE217DBF17

Q38184953-A5F0929B-F940-4A02-A9B5-B13AF064865C

P304

Q38184953-30797183-8C83-4825-B794-499C662C459F

P31

Q38184953-D71487BF-3900-4507-9F59-B7566EC741DE

P356

Q38184953-D9C12C0D-9282-4026-9492-FBFC5F2234E5

P433

Q38184953-82E5D78A-FE2D-45C0-975E-1C3F94886D1D

P478

Q38184953-56E26222-ED9C-45B8-A718-30ACE25F90B9

P50

Q38184953-AE953E16-9713-42A7-B49B-1FC5804DAD19

Q38184953-E378312F-3721-4C3B-9C0E-F726E3813B2F

P577

Q38184953-68BC5C55-A65E-4B76-8F9D-4299F0F3775C

P698

Q38184953-EB2C1879-FA4E-4C3E-8BF8-244347EDCD2A

P356

S10067-014-2507-4

P1433

Clinical Rheumatology

P1476

Abatacept as a successful therapy for myositis—a case-based review

@en

P2093

Anne M Kerola

http://www.w3.org/2001/XMLSchema#string

Markku J Kauppi

http://www.w3.org/2001/XMLSchema#string

P2860

Rituximab in the treatment of refractory adult and juvenile dermatomyositis and adult polymyositis: a randomized, placebo-phase trial.

A randomized, pilot trial of etanercept in dermatomyositis.

Possible role for tumour necrosis factor inhibitors in the treatment of resistant dermatomyositis and polymyositis: a retrospective study of eight patients.

Expression of the costimulatory molecule BB-1, the ligands CTLA-4 and CD28, and their mRNA in inflammatory myopathies.

Abatacept and sodium thiosulfate for treatment of recalcitrant juvenile dermatomyositis complicated by ulceration and calcinosis.

Effect of Alemtuzumab (CAMPATH 1-H) in patients with inclusion-body myositis.

A phase 1b clinical trial evaluating sifalimumab, an anti-IFN-α monoclonal antibody, shows target neutralisation of a type I IFN signature in blood of dermatomyositis and polymyositis patients

Treatment of adult inflammatory myositis with rituximab: an emerging therapy for refractory patients.

The inhibitor of costimulation of T cells: abatacept.

Therapeutic advances in myositis.

P304

609-612

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S10067-014-2507-4

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

34

http://www.w3.org/2001/XMLSchema#string

P50

P577

2014-02-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24493331

http://www.w3.org/2001/XMLSchema#string